Chemotherapy in advanced bladder cancer: current status and future
about
IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma.Decrement of miR-199a-5p contributes to the tumorigenesis of bladder urothelial carcinoma by regulating MLK3/NF-κB pathwayCisplatin-induced nephrotoxicity and targets of nephroprotection: an update.Preclinical models in electrochemotherapy: the role of veterinary patients.Animal models of urinary bladder cancer and their application to novel drug discovery.The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery.Sensing cisplatin-induced permeation of single live human bladder cancer cells by scanning electrochemical microscopy.Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity.miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2.Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survivalIntravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer.
P2860
Q35987440-048DF299-9282-4307-A0F7-F8E644C153E0Q36516725-C6E5AE19-D7C3-48D2-8036-34F814DF4096Q37989844-0261B542-0904-4CD2-A685-027050EAFF2CQ38029365-D0E88935-C14D-41EB-B81A-4D3CFD617821Q38199547-188E4121-C025-4E37-8F04-6D06A2947AF4Q38211604-7964F3AB-8045-4CA4-935E-72BD60868DDEQ38220806-0E7FA638-1514-4B9B-ABB1-C305E1C15DF9Q38808040-BF00D8CF-2C0D-4007-A121-99B661728AAEQ38851041-F5F88D5F-6C8E-46AA-970B-B7DC87E36240Q38891996-80B77540-A149-4C8D-858B-BC5656077F9AQ38982389-BEEB2D97-E53C-403E-8D67-4A52DFBF5780Q39031180-436A4F0F-350B-4320-9A63-A25322E39B0BQ39132853-1B1C313D-064E-4196-93F7-85F6785A4E76Q39169203-A9BF75CF-AE98-4BEE-9986-BE99107E0847Q39861038-DE8F1FD2-AB86-4768-9B29-D3525403F35BQ41455651-5639643E-F329-48C1-8241-903B0CCD39F3Q49959107-5C6B064A-EC6F-486A-8F97-9A1A9C4AB451Q50527665-1C12AB66-5F67-4BCF-A5A0-E065852C7552
P2860
Chemotherapy in advanced bladder cancer: current status and future
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemotherapy in advanced bladder cancer: current status and future
@ast
Chemotherapy in advanced bladder cancer: current status and future
@en
type
label
Chemotherapy in advanced bladder cancer: current status and future
@ast
Chemotherapy in advanced bladder cancer: current status and future
@en
prefLabel
Chemotherapy in advanced bladder cancer: current status and future
@ast
Chemotherapy in advanced bladder cancer: current status and future
@en
P2093
P2860
P921
P356
P1476
Chemotherapy in advanced bladder cancer: current status and future
@en
P2093
Aude Flechon
Mounia Amzerin
Nabil Ismaili
P2860
P2888
P356
10.1186/1756-8722-4-35
P5008
P577
2011-09-09T00:00:00Z
P5875
P6179
1032187483